DENTSPLY SIRONA Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter net sales of $836 million and a net loss attributable to the company of $2 million.

Key Highlights

  • Net sales: $836 million for the three months ended September 30, 2026, compared with $904 million in the same period of 2025, according to the filing.
  • Net loss attributable to Dentsply Sirona: $2 million for Q3 2026, versus a net loss of $427 million in Q3 2025.
  • Nine-month net sales: $2,614 million for the nine months ended September 30, 2026, compared with $2,719 million for the same period in 2025.
  • Nine-month net income: $25 million attributable to Dentsply Sirona for the nine months ended September 30, 2026, versus a net loss of $452 million in the prior-year period.
  • Goodwill and intangible asset impairments: $3 million in Q3 2026, compared with $262 million in Q3 2025 and $497 million for the nine months ended September 30, 2025.
  • Shares outstanding: 198,153,678 shares of common stock as of October 23, 2026, the filing disclosed.
  • Total assets: $5,190 million at September 30, 2026, down from $5,429 million at December 31, 2025.

Dentsply Sirona Third-Quarter 2026 Financial Results

According to the Form 10-Q filed on NASDAQ:XRAY, Dentsply Sirona reported net sales of $836 million for the three months ended September 30, 2026, a decline from $904 million in the comparable prior-year quarter. Gross profit was $443 million in Q3 2026 versus $441 million in Q3 2025. Operating income was $37 million for the quarter, compared with an operating loss of $218 million in Q3 2025, with the prior-year period heavily affected by $262 million in goodwill and intangible asset impairments. The company reported Q3 2026 impairments of $3 million.

For the nine months ended September 30, 2026, the company disclosed net sales of $2,614 million versus $2,719 million for the same period in 2025. Nine-month operating income was $84 million, compared with an operating loss of $283 million a year earlier. The nine-month provision for income taxes was $33 million in 2026 versus $114 million in 2025. Basic and diluted earnings per share attributable to Dentsply Sirona were $0.12 for the nine months ended September 30, 2026, compared with a loss of $2.27 per share in the prior-year period.

On the balance sheet, the filing reported total assets of $5,190 million at September 30, 2026, compared with $5,429 million at December 31, 2025. Cash and cash equivalents were $195 million, down from $326 million at year-end 2025. Long-term debt stood at $1,985 million. Total Dentsply Sirona equity was $1,355 million at September 30, 2026, versus $1,339 million at December 31, 2025. The accumulated deficit was $1,539 million at September 30, 2026, compared with $1,564 million at December 31, 2025. The filing noted restructuring and other income of $2 million in Q3 2026, compared with restructuring and other expenses of $5 million in Q3 2025.

What Was Disclosed

Dentsply Sirona's 10-Q for the quarter ended September 30, 2026 disclosed quarterly net sales of $836 million, a net loss attributable to the company of $2 million, total assets of $5,190 million, and 198,153,678 common shares outstanding as of October 23, 2026.